Comparative analyses of proteins from Haemophilus influenzae biofilm and planktonic populations using metabolic labeling and mass spectrometry

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Post, Deborah M B ^a   Held, Jason M ^b   Ketterer, Margaret R ^c   Phillips, Nancy J ^d   Sahu, Alexandria ^a   Apicella, Michael A ^c   Gibson, Bradford W ^a,d  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biofilms; Mass spectrometry; Metabolic labeling; Non typeable haemophilus influenzae

Indexed keywords

AEROBIC RESPIRATION CONTROL PROTEIN A; BACTERIAL PROTEIN; ISOLEUCINE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; NUCLEOSIDE; NUCLEOTIDE; PURINE; PYRIMIDINE; STABLE ISOTOPE; PROTEOME;

ARTICLE; BACTERIAL METABOLISM; BIOFILM; CONTINUOUS CULTURE; CONTROLLED STUDY; DNA METABOLISM; DNA TRANSCRIPTION; DOWN REGULATION; ENERGY METABOLISM; FATTY ACID METABOLISM; HAEMOPHILUS INFLUENZAE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; NONHUMAN; PHOSPHOLIPID METABOLISM; PLANKTON; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; MASS SPECTROMETRY; PHYSIOLOGY;

ARCA; BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE;

BACTERIAL PROTEINS; BIOFILMS; CHROMATOGRAPHY, LIQUID; HAEMOPHILUS INFLUENZAE; ISOTOPE LABELING; MASS SPECTROMETRY; PROTEOME;

EID: 84923934687     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0329-9     Document Type: Article

References (81)

1. Agrawal A, Murphy TF: Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol 2011, 49(11):3728-3732.
2. Erwin AL, Smith AL: Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 2007, 15(8):355-362.
3. Foxwell AR, Kyd JM, Cripps AW: Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev 1998, 62(2):294-308.
4. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI: Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J 2009, 28(1):43-48.
5. Moghaddam SJ, Ochoa CE, Sethi S, Dickey BF: Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis 2011, 6: 113-123.
6. Greiner LL, Watanabe H, Phillips NJ, Shao J, Morgan A, Zaleski A, Gibson BW, Apicella MA: Nontypeable Haemophilus influenzae strain 2019 produces a biofilm containing N-acetylneuraminic acid that may mimic sialylated O-linked glycans. Infect Immun 2004, 72(7):4249-4260.
7. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE: Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296(2):202-211.
8. Hong W, Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE: Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun 2007, 75(2):958-965.
9. Hong W, Pang B, West-Barnette S, Swords WE: Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J Bacteriol 2007, 189(22):8300-8307.
10. Jurcisek J, Greiner L, Watanabe H, Zaleski A, Apicella MA, Bakaletz LO: Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear. Infect Immun 2005, 73(6):3210-3218.
11. Murphy TF, Kirkham C: Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol 2002, 2:7.
12. Swords WE, Moore ML, Godzicki L, Bukofzer G, Mitten MJ, VonCannon J: Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect Immun 2004, 72(1):106-113.
13. Banat IM, De Rienzo MA, Quinn GA: Microbial biofilms: biosurfactants as antibiofilm agents. Appl Microbiol Biotechnol 2014, 98(24): 9915-29.
14. Fux CA, Costerton JW, Stewart PS, Stoodley P: Survival strategies of infectious biofilms. Trends Microbiol 2005, 13(1):34-40.
15. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O: Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010, 35(4):322-332.
16. Seneviratne CJ, Wang Y, Jin L, Wong SS, Herath TD, Samaranayake LP: Unraveling the resistance of microbial biofilms: has proteomics been helpful? Proteomics 2012, 12(4-5):651-665.
17. Bakaletz LO: Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J 2007, 26(10 Suppl):S17-S19.
18. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112(10):1466-1477.
19. Kyd JM, McGrath J, Krishnamurthy A: Mechanisms of bacterial resistance to antibiotics in infections of COPD patients. Curr Drug Targets 2011, 12(4):521-530.
20. Flemming HC, Wingender J: The biofilm matrix. Nat Rev Microbiol 2010, 8(9):623-633.
21. Allen S, Zaleski A, Johnston JW, Gibson BW, Apicella MA: Novel sialic acid transporter of Haemophilus influenzae. Infect Immun 2005, 73(9):5291-5300.
22. Bakaletz LO, Baker BD, Jurcisek JA, Harrison A, Novotny LA, Bookwalter JE, Mungur R, Munson RS Jr: Demonstration of Type IV pilus expression and a twitching phenotype by Haemophilus influenzae. Infect Immun 2005, 73(3):1635-1643.
23. Carruthers MD, Tracy EN, Dickson AC, Ganser KB, Munson RS Jr, Bakaletz LO: Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons. J Bacteriol 2012, 194(8):1927-1933.
24. Izano EA, Shah SM, Kaplan JB: Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms. Microb Pathog 2009, 46(4):207-213.
25. Jurcisek JA, Bakaletz LO: Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein. J Bacteriol 2007, 189(10):3868-3875.
26. Lanucara F, Eyers CE: Mass spectrometric-based quantitative proteomics using SILAC. Methods Enzymol 2011, 500:133-150.
27. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M: Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1(5):376-386.
28. Ong SE, Mann M: Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005, 1(5):252-262.
29. Dreisbach A, Otto A, Becher D, Hammer E, Teumer A, Gouw JW, Hecker M, Volker U: Monitoring of changes in the membrane proteome during stationary phase adaptation of Bacillus subtilis using in vivo labeling techniques. Proteomics 2008, 8(10):2062-2076.
30. Phillips NJ, Steichen CT, Schilling B, Post DM, Niles RK, Bair TB, Falsetta ML, Apicella MA, Gibson BW: Proteomic analysis of Neisseria gonorrhoeae biofilms shows shift to anaerobic respiration and changes in nutrient transport and outermembrane proteins. PLoS One 2012, 7(6):e38303.
31. Ruiz L, Coute Y, Sanchez B, de los Reyes-Gavilan CG, Sanchez JC, Margolles A: The cell-envelope proteome of Bifidobacterium longum in an in vitro bile environment. Microbiology 2009, 155(Pt 3):957-967.
32. Soufi B, Kumar C, Gnad F, Mann M, Mijakovic I, Macek B: Stable isotope labeling by amino acids in cell culture (SILAC) applied to quantitative proteomics of Bacillus subtilis. J Proteome Res 2010, 9(7):3638-3646.
33. Yu JL, Guo L: Quantitative proteomic analysis of Salmonella enterica serovar Typhimurium under PhoP/PhoQ activation conditions. J Proteome Res 2011, 10(7):2992-3002.
34. Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA: Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun 1987, 55(4):882-887.
35. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP: Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001, 413(6858):860-864.
36. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA: The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007, 6(9):1638-1655.
37. Harrison A, Dyer DW, Gillaspy A, Ray WC, Mungur R, Carson MB, Zhong H, Gipson J, Gipson M, Johnson LS, Lewis L, Bakaletz LO, Munson RS Jr: Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20. J Bacteriol 2005, 187(13):4627-4636.
38. Tang WH, Shilov IV, Seymour SL: Nonlinear fitting method for determining local false discovery rates from decoy database searches. J Proteome Res 2008, 7(9):3661-3667.
39. J. Craig Venter Institute Comprehensive Microbial Resource. http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi
40. Protein knowledgebase (UniProtKB). http://www.uniprot.org/
41. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, Brinkman FS: PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010, 26 (13):1608-1615.
42. Maclean B, Tomazela DM, Abbatiello SE, Zhang S, Whiteaker JR, Paulovich AG, Carr SA, Maccoss MJ: Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem 2010, 82(24):10116-10124.
43. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ: Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26(7):966-968.
44. Post D, JM Held, MR Ketterer, NJ Phillips, A Sahu, MA Apicella, and BW Gibson: Haemophilus influezae proteomics data from unlabeled planktonic and metabolically labeled biofilm samples. massIVE ftp site ftp://MSV000078838@massive.ucsd.edu.
45. KEGG website. http://www.genome.jp/kegg/
46. Qu J, Lesse AJ, Brauer AL, Cao J, Gill SR, Murphy TF: Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses. BMC Microbiol 2010, 10:162.
47. van der Woude MW: Phase variation: how to create and coordinate population diversity. Curr Opin Microbiol 2011, 14(2):205-211.
48. Weiser JN: The generation of diversity by Haemophilus influenzae. Trends Microbiol 2000, 8(10):433-435.
49. De Bolle X, Bayliss CD, Field D, van de Ven T, Saunders NJ, Hood DW, Moxon ER: The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol Microbiol 2000, 35 (1):211-222.
50. Poole J, Foster E, Chaloner K, Hunt J, Jennings MP, Bair T, Knudtson K, Christensen E, Munson RS Jr, Winokur PL, Apicella MA: Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis 2013, 208(5):720-727.
51. van Ham SM, van Alphen L, Mooi FR, van Putten JP: Phase variation of H. influenzae fimbriae: transcriptional control of two divergent genes through a variable combined promoter region. Cell 1993, 73(6):1187-1196.
52. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, Pitts B, Stewart PS: Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004, 70(10):6188-6196.
53. Oppenheimer-Shaanan Y, Steinberg N, Kolodkin-Gal I: Small molecules are natural triggers for the disassembly of biofilms. Trends Microbiol 2013, 21(11):594-601.
54. Klausen M, Gjermansen M, Kreft JU, Tolker-Nielsen T: Dynamics of development and dispersal in sessile microbial communities: examples from Pseudomonas aeruginosa and Pseudomonas putida model biofilms. FEMS Microbiol Lett 2006, 261(1):1-11.
55. Pang B, Hong W, Kock ND, Swords WE: Dps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivo. Front Cell Infect Microbiol 2012, 2:58.
56. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ: Tracking insertion mutants within libraries by deep sequencing and a genomewide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 2009, 106(38):16422-16427.
57. Murphy TF, Kirkham C, Sethi S, Lesse AJ: Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection. FEMS Immunol Med Microbiol 2005, 44(1):81-89.
58. Hall-Stoodley L, Stoodley P: Evolving concepts in biofilm infections. Cell Microbiol 2009, 11(7):1034-1043.
59. Martinez JL, Rojo F: Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev 2011, 35(5):768-789.
60. Fux CA, Wilson S, Stoodley P: Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 2004, 186(14):4486-4491.
61. Anderl JN, Zahller J, Roe F, Stewart PS: Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003, 47(4):1251-1256.
62. De Souza-Hart JA, Blackstock W, Di Modugno V, Holland IB, Kok M: Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance. Infect Immun 2003, 71(1):163-172.
63. Georgellis D, Kwon O, Lin EC, Wong SM, Akerley BJ: Redox signal transduction by the ArcB sensor kinase of Haemophilus influenzae lacking the PAS domain. J Bacteriol 2001, 183(24):7206-7212.
64. Wong SM, Alugupalli KR, Ram S, Akerley BJ: The ArcA regulon and oxidative stress resistance in Haemophilus influenzae. Mol Microbiol 2007, 64(5):1375-1390.
65. Lynch AS, Lin ECC (Eds): Responses to molecular oxygen. Washington: DC ASM Press; 1996.
66. Othman DS, Schirra H, McEwan AG, Kappler U: Metabolic versatility in Haemophilus influenzae: a metabolomic and genomic analysis. Front Microbiol 2014, 5:69.
67. Kemmer G, Reilly TJ, Schmidt-Brauns J, Zlotnik GW, Green BA, Fiske MJ, Herbert M, Kraiss A, Schlor S, Smith A, Reidl J: NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae. J Bacteriol 2001, 183(13):3974-3981.
68. Reidl J, Schlor S, Kraiss A, Schmidt-Brauns J, Kemmer G, Soleva E: NADP and NAD utilization in Haemophilus influenzae. Mol Microbiol 2000, 35(6):1573-1581.
69. Mason KM, Raffel FK, Ray WC, Bakaletz LO: Heme utilization by nontypeable Haemophilus influenzae is essential and dependent on Sap transporter function. J Bacteriol 2011, 193(10):2527-2535.
70. Cope LD, Thomas SE, Latimer JL, Slaughter CA, Muller-Eberhard U, Hansen EJ: The 100 kDa haem:haemopexin-binding protein of Haemophilus influenzae: structure and localization. Mol Microbiol 1994, 13(5):863-873.
71. Hanson MS, Slaughter C, Hansen EJ: The hbpA gene of Haemophilus influenzae type b encodes a heme-binding lipoprotein conserved among heme-dependent Haemophilus species. Infect Immun 1992, 60(6):2257-2266.
72. Jarosik GP, Sanders JD, Cope LD, Muller-Eberhard U, Hansen EJ: A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b. Infect Immun 1994, 62(6):2470-2477.
73. Maciver I, Latimer JL, Liem HH, Muller-Eberhard U, Hrkal Z, Hansen EJ: Identification of an outer membrane protein involved in utilization of hemoglobin-haptoglobin complexes by nontypeable Haemophilus influenzae. Infect Immun 1996, 64(9):3703-3712.
74. Morton DJ, Bakaletz LO, Jurcisek JA, VanWagoner TM, Seale TW, Whitby PW, Stull TL: Reduced severity of middle ear infection caused by nontypeable Haemophilus influenzae lacking the hemoglobin/hemoglobin-haptoglobin binding proteins (Hgp) in a chinchilla model of otitis media. Microb Pathog 2004, 36(1):25-33.
75. Morton DJ, Madore LL, Smith A, Vanwagoner TM, Seale TW, Whitby PW, Stull TL: The heme-binding lipoprotein (HbpA) of Haemophilus influenzae: role in heme utilization. FEMS Microbiol Lett 2005, 253(2):193-199.
76. Morton DJ, Smith A, Ren Z, Madore LL, VanWagoner TM, Seale TW, Whitby PW, Stull TL: Identification of a haem-utilization protein (Hup) in Haemophilus influenzae. Microbiology 2004, 150(Pt 12):3923-3933.
77. Sanders JD, Cope LD, Hansen EJ: Identification of a locus involved in the utilization of iron by Haemophilus influenzae. Infect Immun 1994, 62(10):4515-4525.
78. Hanson MS, Hansen EJ: Molecular cloning, partial purification, and characterization of a haemin-binding lipoprotein from Haemophilus influenzae type b. Mol Microbiol 1991, 5(2):267-278.
79. Vergauwen B, Elegheert J, Dansercoer A, Devreese B, Savvides SN: Glutathione import in Haemophilus influenzae Rd is primed by the periplasmic heme-binding protein HbpA. Proc Natl Acad Sci U S A 2010, 107(30):13270-13275.
80. Morton DJ, Seale TW, Bakaletz LO, Jurcisek JA, Smith A, VanWagoner TM, Whitby PW, Stull TL: The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant. Int J Med Microbiol 2009, 299(7):479-488.
81. Cain JA, Solis N, Cordwell SJ: Beyond gene expression: The impact of protein post-translational modifications in bacteria. J Proteomics 2014, 97:265-286.